[go: up one dir, main page]

CN102886003A - Traditional Chinese medicine composition for treating rheumatoid arthritis - Google Patents

Traditional Chinese medicine composition for treating rheumatoid arthritis Download PDF

Info

Publication number
CN102886003A
CN102886003A CN2012104266217A CN201210426621A CN102886003A CN 102886003 A CN102886003 A CN 102886003A CN 2012104266217 A CN2012104266217 A CN 2012104266217A CN 201210426621 A CN201210426621 A CN 201210426621A CN 102886003 A CN102886003 A CN 102886003A
Authority
CN
China
Prior art keywords
parts
chinese medicine
traditional chinese
rheumatoid arthritis
medicine composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2012104266217A
Other languages
Chinese (zh)
Inventor
石欣
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2012104266217A priority Critical patent/CN102886003A/en
Publication of CN102886003A publication Critical patent/CN102886003A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention provides a traditional Chinese medicine composition for treating rheumatoid arthritis, and the traditional Chinese medicine composition is prepared from the following raw medicinal materials in parts by weight: 12 parts of white mulberry branch, 20 parts of honeysuckle stem, 20 parts of suberect spatholobus stem, 20 parts of glabrous greenbrier rhizome, 15 parts of white paeony root, 10 parts of gentiana macrophylla, 10 parts of radix angelicae sinensis, 10 parts of silkworm feces, 15 parts of herba siegesbeckiae, 15 parts of corn kernel, 15 parts of fourstamen stephania root and 5 parts of licorice root. The traditional Chinese medicine composition provided by the invention is a pure traditional Chinese medicine preparation, has no toxic or side effect and has a remarkable effect of treating the rheumatoid arthritis.

Description

A kind of Chinese medicine composition for the treatment of rheumatoid arthritis
Technical field
The present invention relates to a kind of medicine for the treatment of rheumatoid arthritis, be specifically related to a kind of Chinese medicine composition for the treatment of rheumatoid arthritis.
Background technology
Rheumatoid arthritis is common clinical, frequently-occurring disease, belong to the category of arthromyodynia in the traditional Chinese medical science, red, swollen, hot with the part, bitterly, get cold then relaxing and be principal character, can accompany General Symptoms, heating, afternoon body temperature 37-38 degree centigrade, the symptoms such as sweating, dry stool, thirsty, red tongue, yellow fur, rapid pulse, Clinical Laboratory shows that erythrocyte sedimentation rate, anti-" O " are higher than normally, and rheumatoid factor is positive.Now in the medicine of usefulness, it is a lot of to treat rheumatoid medicine, cuts but exist uncertain therapeutic efficacy, and the course for the treatment of is long, the problem that can not effect a radical cure.
Summary of the invention
In order to solve the problems of the technologies described above, the invention provides a kind of Chinese medicine composition for the treatment of rheumatoid arthritis.
Technical scheme of the present invention is as follows:
A kind of Chinese medicine composition for the treatment of rheumatoid arthritis, crude drug by following weight portion is prepared from: Ramulus Mori 12, Caulis Lonicerae 20, Caulis Spatholobi 20, Rhizoma Smilacis Glabrae 20, the Radix Paeoniae Alba 15, Radix Gentianae Macrophyllae 10, Radix Angelicae Sinensis 10, Bombyx mori L. 10, Herba Siegesbeckiaes 15, Semen Maydis core 15,, Radix Stephaniae Tetrandrae 15, Radix Glycyrrhizae 5.
Preparation method: get above each flavor, the decocting that adds 10 times, 8 times amounts boils twice, and each 2 hours, filter, merging filtrate, it is for subsequent use to be concentrated into 200ml.
We are damp and hot with Caulis Lonicerae, the clear meridians of Semen Maydis core joint; The detoxifcation of Lian Qiao Cheongju battalion, inducing Ying heat into Qi phase enter the heart, lung, Liver Channel, the cohesion of loose QI and blood; The Rhizoma Smilacis Glabrae easing joint movement, the detoxifcation dehumidifying, disconnected its wet source is monarch drug.Assistant is namely invigorated blood circulation with Radix Angelicae Sinensis, Caulis Spatholobi, can enrich blood again, has the rheumatic arthralgia of the stasis of blood the most suitable to blood deficiency; Radix Stephaniae Tetrandrae damp eliminating detumescence, current twelve regular channels promoting the circulation of blood blood stasis dispelling is wet by the network tunnel; Bombyx mori L. is led turbid clear network, and it is sluggish to dredge all warps, and sick relatively stagnant heat person must use for numbness; With Ramulus Mori, Herba Siegesbeckiae dredge the meridian passage, Radix Paeoniae Alba joint venture yin fluid astringing, solution contraction; The Radix Gentianae Macrophyllae Shujin delays convulsion, joins Radix Glycyrrhizae and coordinates the effect that all medicines are played the slow convulsion of collateral dredging altogether.Jointly reach the treatment to rheumatoid arthritis.
Clinical data
1. case is originated: rheumatoid arthritis patients to our hospital, totally 80 examples.
2. diagnostic criteria:
2.1 criteria for classification in 1987 of Western medicine diagnose standard reference American Rheumatism Association revision, possess 4 persons in following 7: (1) deadlock in morning is 1h at least, persistent period 〉=6 week; (2) 3 or 3 above swollen joints, persistent period 〉=6 week; (3) wrist, the palm refer to, proximal interphalangeal joint is swollen, persistent period 〉=6 week; (4) symmetry swollen joint, persistent period 〉=6 week; (5) subcutaneous nodule; (6) the x line of hands and wrist changes (having at least osteoporosis and joint to ask that the crack is narrow); (7) rheumatoid factor (RF) positive.
2.2 tcm syndrome is dialectical according to reference " new Chinese medicine guideline of clinical investigations ".Syndrome of cold-dampness blocking collaterals (anemofrigid-damp arthralgia, cold-damp folder stasis of blood type]): arthralgia swelling, local fear of cold, color of the leather are not red, and that touches is not hot, the joint joint stuffiness, morning is stiff, joint deformity.Inferior disease: lusterless complexion, the limbs fear of cold, clear urine in large amounts, it is normal or rare half congealed to defecate.White or the whiten of pale tongue tongue, deep-slow pulse or heavy weak or heavy tight or heavy sliding slow.
3. criterion of therapeutical effect
Criterion of therapeutical effect is with reference to " new Chinese medicine guideline of clinical investigations ".
Clinical cure: symptom all disappears, and it is normal that functional activity recovers, and main doctor trained in Western medicine physico-chemical examination index is normal;
Produce effects: symptomatology disappears or cardinal symptom is eliminated, and function of joint is recovered substantially, can participate in normal operation and work, physico-chemical examination index normal;
Effectively: the cardinal symptom elimination, main function of joint is substantially recovered or is had made marked progress, and can't take care of oneself transfers self-care to, perhaps loses the job and work capacity transfers work to and ability to work is recovered to some extent, and mainly the physico-chemical examination index makes moderate progress;
Invalid: and compare before the treatment, each side is all without progressive.
3. therapeutic scheme: take the present invention and prepare medicine, a weight portion is potion, every day potion, minute morning, noon and afternoon take for three times, seven days is a course for the treatment of.Observe the curative effect after 3 courses for the treatment of.
4. therapeutic outcome
After 3 courses for the treatment of, clinical cure 22 examples wherein, produce effects 40 examples, effective 15 examples, invalid 5 examples, total effective rate reaches 93.7%.
Can find out that by above test cured substance rate of the present invention is high, can be used for clinical treatment.
 
The specific embodiment
The present invention is further illustrated below in conjunction with embodiment.
Embodiment 1
Take by weighing Ramulus Mori 12g, Caulis Lonicerae 20g, Caulis Spatholobi 20g, Rhizoma Smilacis Glabrae 20g, Radix Paeoniae Alba 15g, Radix Gentianae Macrophyllae 10g, Radix Angelicae Sinensis 10g, Bombyx mori L. 10g, Herba Siegesbeckiae 15g, Semen Maydis core 15 g,, Radix Stephaniae Tetrandrae 15g, Radix Glycyrrhizae 5g.The decocting that adds 10 times, 8 times amounts boils twice, and each 2 hours, filter, merging filtrate, it is for subsequent use to be concentrated into 200ml.
Model case
Case 1
Open XX, women, 58 years old.The patient examine the two ankles of main suit, knee joint, shoulder joint morning stiff, swell and ache, on inspection arthroncus and deformity, ESR ↑, RF(+), be diagnosed as rheumatoid arthritis.Processing procedure: take medicine of the present invention, take the embodiment of the invention 1 preparation medicine, a prescription is potion, every day potion, curative effect: through week treatment, swelling pain disappears, and check ESR and RF after 3 weeks recover normal, look steadily it and continue to take drug withdrawal after 2 months, follow up a case by regular visits to after 1 year, without recurrence.
Case 2
Lee XX, the women, 60 years old, both hands arthroncus and deformity had 5 years, began first both hands middle interphalangeal arthralgia, engendered ankylosis, deformity, occurred other arthralgia deformities after 1 year, and early morning, ankylosis was obvious, alleviated relevant with Changes in weather after the activity.Check: both hands arthroncus and deformity, suffer from and refer to that tenderness is obvious on every side.Joint motion is obviously limited, and both hands interphalangeal joint gap turn narrow is shown in the x-ray inspection, ESR ↑ and, RF(+).Be diagnosed as rheumatoid arthritis.Processing procedure: take the embodiment of the invention 1 preparation medicine, a prescription is potion, every day potion, curative effect: through week treatment, the both hands joint is without pain, and check ESR and RF after 2 weeks recover normal, look steadily it to take drug withdrawal after 1 month, follow up a case by regular visits to after 1 year, without recurrence.

Claims (1)

1. Chinese medicine composition for the treatment of rheumatoid arthritis, it is characterized in that, crude drug by following weight portion is prepared from: Ramulus Mori 12, Caulis Lonicerae 20, Caulis Spatholobi 20, Rhizoma Smilacis Glabrae 20, the Radix Paeoniae Alba 15, Radix Gentianae Macrophyllae 10, Radix Angelicae Sinensis 10, Bombyx mori L. 10, Herba Siegesbeckiaes 15, Semen Maydis core 15,, Radix Stephaniae Tetrandrae 15, Radix Glycyrrhizae 5.
CN2012104266217A 2012-10-31 2012-10-31 Traditional Chinese medicine composition for treating rheumatoid arthritis Pending CN102886003A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2012104266217A CN102886003A (en) 2012-10-31 2012-10-31 Traditional Chinese medicine composition for treating rheumatoid arthritis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2012104266217A CN102886003A (en) 2012-10-31 2012-10-31 Traditional Chinese medicine composition for treating rheumatoid arthritis

Publications (1)

Publication Number Publication Date
CN102886003A true CN102886003A (en) 2013-01-23

Family

ID=47529820

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2012104266217A Pending CN102886003A (en) 2012-10-31 2012-10-31 Traditional Chinese medicine composition for treating rheumatoid arthritis

Country Status (1)

Country Link
CN (1) CN102886003A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104740155A (en) * 2013-12-27 2015-07-01 刘峰 Traditional Chinese medicine for treating rheumatoid arthritis
CN105582217A (en) * 2016-03-01 2016-05-18 林炜 Traditional Chinese medicine composition for treating rheumatoid arthritis
CN105853825A (en) * 2016-05-19 2016-08-17 张锦凡 Traditional Chinese medicine composition gel for treating rheumatic arthritis and preparation method of traditional Chinese medicine composition gel
CN105853827A (en) * 2016-06-02 2016-08-17 瑞安市智造科技有限公司 Medical microfilament for treating rheumatic arthritis and preparation method thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1342462A (en) * 2000-09-08 2002-04-03 何兴峰 Composite medicine for treating rheumatoid arthritis
CN102205070A (en) * 2011-05-27 2011-10-05 张家旺 Medicament for treating rheumatoid diseases and preparation method thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1342462A (en) * 2000-09-08 2002-04-03 何兴峰 Composite medicine for treating rheumatoid arthritis
CN102205070A (en) * 2011-05-27 2011-10-05 张家旺 Medicament for treating rheumatoid diseases and preparation method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
于建华 等: "通络息风汤", 《二十世纪中医药最佳处方》 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104740155A (en) * 2013-12-27 2015-07-01 刘峰 Traditional Chinese medicine for treating rheumatoid arthritis
CN105582217A (en) * 2016-03-01 2016-05-18 林炜 Traditional Chinese medicine composition for treating rheumatoid arthritis
CN105853825A (en) * 2016-05-19 2016-08-17 张锦凡 Traditional Chinese medicine composition gel for treating rheumatic arthritis and preparation method of traditional Chinese medicine composition gel
CN105853827A (en) * 2016-06-02 2016-08-17 瑞安市智造科技有限公司 Medical microfilament for treating rheumatic arthritis and preparation method thereof

Similar Documents

Publication Publication Date Title
CN104523865B (en) Medicine for treating breast diseases
CN100376229C (en) A medicinal wine for treating rheumatic and rheumatoid disease
CN101167874B (en) Traditional Chinese medicinal composition for treating rheumatic arthritis and rheumatoid oarthritis
CN103316295B (en) Traditional Chinese composition for treating rheumatic arthritis
CN102886003A (en) Traditional Chinese medicine composition for treating rheumatoid arthritis
CN102058784A (en) Medicinal composition for treating pulmonary heart disease and application thereof
CN102475868B (en) Anti-rheumatism medicinal liquor
CN105770629A (en) Traditional Chinese medicine for treating acute gouty arthritis
CN105641564A (en) Medicine for treating gouty arthritis by combining oral administration and external application of traditional Chinese medicines
CN101239159B (en) Chinese medicinal composition for treating rheumatoild disease and preparation thereof
CN102100854A (en) Chinese medicinal composition for treating rheumatic arthritis
CN102895572B (en) Traditional Chinese medical composition for treatment of rheumatoid arthritis
CN104173564A (en) Traditional Chinese medicine composition for treating rheumatoid arthritis
CN100546640C (en) A kind of Chinese medicine composition of orally taken for curing cyclomastopathy
CN101244181B (en) Plaster for bone paralysis with function of qufengshengshi, blood circulation activating and stasis removing, and removing the obstruction in the channels to relieve pain, and preparation thereof
CN103768214B (en) A kind of Chinese medicine composition for the treatment of kidney yang deficiency syndrome rhinitis
CN103768230A (en) Traditional Chinese medicinal fumigation lotion for treating rheumatoid arthritis
CN103393909A (en) Chinese medicinal preparation for treating biliary calculus with cholecystitis
CN103893600B (en) A kind of Chinese medicine composition for the treatment of scapulohumeral periarthritis
CN101361934B (en) Traditional Chinese medicine preparation for treating arthritis and various osteonosus
CN102861195B (en) Drug composition for treating rheumatism pain
CN105688096A (en) Traditional Chinese medicine composition for treating gout
CN106266788A (en) A kind of treat the soothing the liver removing toxic substances of gouty arthritis, QiReLiShi herbs compositions
CN104857335A (en) Traditional Chinese medicine for treating absorption fever in early stage of femoral shaft fracture trauma
CN102406868B (en) Chinese medicine for treating rheumarthritis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20130123